This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kennel, S. J. Search for Related Content PubMed PubMed Citation Articles by Kennel, S. J.

Effects of Target Antigen Competition on Distribution of Monoclonal Antibody to Solid Tumors¹

Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831-8077

Monoclonal antibody (MoAb) 11A and MoAb 13A recognize normal murine cell surface glycoproteins, which are also expressed in high concentrations on Line 1 lung carcinoma. Studies were initiated to examine the competition in vivo for radiolabeled MoAb between sites on the tumor versus sites on normal tissue. Quantitative 2-site assay of the ₆ß₄ integrin recognized by MoAb 11A showed that major sites of expression are tumor, intestine, and skin. Microdistribution studies show that at doses of ¹²⁵I-labeled MoAb 11A less than the total body antigen load, the MoAb bound to ß₄ endothelial cells with little extravasation to epithelial sites. As the MoAb dose was increased, and endothelial sites became saturated, deposition at epithelial sites including skin and tumor became apparent.

Quantitative radioimmunoassay with MoAb 13A, recognizing CD44 (P100), demonstrated major sites of expression as tumor, intestine, liver and, to a lesser extent, spleen and skin. Microdistribution studies at low doses of ¹²⁵I-labeled MoAb showed deposition mainly in the liver and spleen sinusoids, whereas higher doses were necessary to maximize MoAb accumulation in tumor. The rapid access of MoAb to target antigen is the most important parameter in efficient localization of MoAb. Access of antigen outside the vascular space is regulated at least in part by the permeability of the endothelial barrier. Of the organs studied, antigen accessibility increases in the following order: lung epithelium < skin epithelium < intestine and uterus epithelium < epithelial tumors < liver and spleen sinusoids < intervascular sites. Antigens in easily accessible sites interact with MoAb first and must be saturated before MoAb will penetrate to less accessible areas. Thus, the extent of competition of antigen for available MoAb depends not only on the amount of antigen, but also on the site at which it is expressed. Doses that achieve maximum binding to tumor sites can be predicted if accurate target antigen quantities and sites of expression are known.

¹ Research sponsored by the Office of Health and Environmental Research, United States Department of Energy, under Contract DE-AC05-840R21400 with the Martin Marietta Energy Systems, Inc. The submitted manuscript has been authored by a contractor of the United States Government under Contract DE-AC05-840R21400.

² To whom requests for reprints should be addressed, at: Biology Division, Oak Ridge National Laboratory, P. O. Box 2009, Oak Ridge, TN 37831-8077.

Received 8/19/91. Accepted 12/11/91.

This article has been cited by other articles:

				T. M. Illidge, M. Bayne, N. S. Brown, S. Chilton, M. S. Cragg, M. J. Glennie, Y. Du, V. Lewington, J. Smart, J. Thom, et al. Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy Blood, February 12, 2009; 113(7): 1412 - 1421. [Abstract] [Full Text] [PDF]

				S. Akkaraju, K. Canaan, and C. C. Goodnow Self-reactive B Cells Are Not Eliminated or Inactivated by Autoantigen Expressed on Thyroid Epithelial Cells J. Exp. Med., December 15, 1997; 186(12): 2005 - 2012. [Abstract] [Full Text] [PDF]

				S. Kennel, T. Lankford, L. Foote, S. Shinpock, and C Stringer CD44 expression on murine tissues J. Cell Sci., January 2, 1993; 104(2): 373 - 382. [Abstract] [PDF]